Krisciunas Gintas P, Vakharia Aneri, Lazarus Cathy, Taborda Stephanie Gomez, Martino Rosemary, Hutcheson Katherine, McCulloch Timothy, Langmore Susan E
Department of Otolaryngology, Boston University Medical Center, Boston, Massachusetts.
Department of Otolaryngology, Icahn School of Medicine at Mount Sinai, New York, New York.
Glob Adv Health Med. 2019 Apr 24;8:2164956119844151. doi: 10.1177/2164956119844151. eCollection 2019.
Radiation-associated dysphagia is a common and debilitating consequence of treatment for head and neck cancer (HNC). Since commonly employed dysphagia therapy programs for HNC patients still lack authoritative efficacy, some speech-language pathologists (SLPs) have started employing manual therapy (MT) techniques in an attempt to prevent or rehabilitate dysphagia in this patient population. However, exceptionally little is known about the use of MT in this patient population.
The purpose of this study was to describe practice patterns as well as the rate, type, and severity of adverse events associated with SLP provision of MT to HNC patients.
An Internet-based questionnaire geared toward SLPs who practice MT was developed and sent to SLPs practicing in the United States, 3 times, through 3 national listservs (American Speech Language Hearing Association [ASHA] Special Interest Division 13, ASHA Special Interest Division 3, and University of Iowa Voiceserv), over the course of 4 weeks.
Of the 255 respondents, 116 (45.5%) performed MT on HNC patients. Of these 116 SLPs, 27.6% provided proactive MT during radiation, 62.1% provided 1 to 2 sessions per week, and 94.8% prescribed a MT home program. The rate, type, and severity of reported adverse events were similar between HNC and non-HNC patients.
This preliminary survey demonstrated that SLPs provide MT to HNC patients during and after cancer treatment, and that reported adverse events paralleled those experienced by noncancer patients. However, these results should be taken with caution, and a well-designed prospective study is needed to formally establish the safety and the preliminary efficacy of this novel clinical intervention.
放射性吞咽困难是头颈部癌(HNC)治疗常见且使人衰弱的后果。由于针对HNC患者常用的吞咽困难治疗方案仍缺乏权威性疗效,一些言语治疗师(SLP)已开始采用手法治疗(MT)技术,试图预防或康复该患者群体的吞咽困难。然而,对于在该患者群体中使用MT的情况知之甚少。
本研究的目的是描述言语治疗师向HNC患者提供MT的实践模式以及不良事件的发生率、类型和严重程度。
针对从事MT的言语治疗师开发了一份基于互联网的问卷,并通过3个全国性邮件列表(美国言语语言听力协会[ASHA]第13特别兴趣小组、ASHA第3特别兴趣小组和爱荷华大学Voiceserv)分3次发送给在美国执业的言语治疗师,为期4周。
在255名受访者中,116名(45.5%)对HNC患者进行了MT。在这116名言语治疗师中,27.6%在放疗期间提供预防性MT,62.1%每周提供1至2次治疗,94.8%规定了家庭MT计划。HNC患者和非HNC患者报告的不良事件发生率、类型和严重程度相似。
这项初步调查表明,言语治疗师在癌症治疗期间和之后为HNC患者提供MT,且报告的不良事件与非癌症患者经历的相似。然而,这些结果应谨慎对待,需要进行精心设计的前瞻性研究,以正式确定这种新型临床干预的安全性和初步疗效。